Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13676 relatives with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13676 relatives with hepatocellular carcinoma

Published:2004-04 Issue:4 Volume:40 Page:653-659
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Chen Chien-Hung,Chen Yang Yuan,Chen Gran-Hum,Yang Sien-Sing,Tang Huang-Shang,Lin Hsien Hong,Lin Deng-Yn,Lo Sing Kai,Du Jeng-Ming,Chang Ting-Tsung,Chen Shinn-Cherng,Liao Li-Ying,Kuo Chung-Huang,Lin Kwo-Chuan,Tai Dar-In,Changchien Chi-Sin,Chang Wen-Yu,Sheu Jin-Chuan,Chen Ding-Shinn,Liaw Yun-Fan,Sung Juei-Low

Publisher

Elsevier BV

Subject

Hepatology

Reference29 articles.

1. Epidemiological characteristics and risk factors of hepatocellular carcinoma;Chen;J Gastroenterol Hepatol,1997

2. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives;Yu;J Natl Cancer Inst,2000

3. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences;Evans;Cancer Epidemiol Biomarkers Prev,2002

4. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers;Yu;Am J Epidemiol,1997

5. Maternal transmission of hepatitis B surface antigen in patients with hepatocellular carcinoma in Taiwan;Sung;Scand J Gastroenterol,1980

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Green Synthesized Nanoparticles as a Plausible Therapeutic Strategy Against Hepatocellular Carcinoma: An Update on its Preclinical and Clinical Relevance;Recent Patents on Anti-Cancer Drug Discovery;2023-08

2. The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study;Virology Journal;2021-11-29

3. Clinical and survival outcomes after hepatectomy in patients with non-alcoholic fatty liver and hepatitis B-related hepatocellular carcinoma;HPB;2021-07

4. ABO-Incompatible Liver Transplantation: State of Art and Future Perspectives;Current Pharmaceutical Design;2020-08-31

5. Liver Cancer;Liver Diseases;2020